- Dragan I, Georgiou T, Prodan N, Akolekar R, Nicolaides KH. Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:73-77 pdf
- Andrietti S, Carlucci S, Wright A, Wright D, Nicolaides KH. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in the prediction of preeclampsia. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17403 pdf
- Panaitescu AM, Wright D, Militello A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17419 pdf
- Wright D, Dragan I, Syngelaki A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:194-200 pdf
- Litwinska M, Wright D, Efeturk T, Ceccacci I, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17418 pdf
- O' Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, Carbone IF, Dutemeyer V, Fiolna M, Frick A, Karagiotis N, Mastrodima S, de Paco Matallana C, Papaioannou G, Pazos A, Plasencia W, Nicolaides KH. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17455 pdf
- Panaitescu AM, Akolekar R, Kametas N, Syngelaki A, Nicolaides KH. Impaired placentation in women with chronic hypertension that develop preeclampsia. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17517 pdf
- O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina FS, de Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides KH. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17399 pdf
- Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LC. A study protocol for the prospective validation study: Screening programme for pre-eclampsia (SPREE). Ultrasound Obstet Gynecol DOI: 10.1002/uog.17467 pdf
- O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE). BMJ Open 2016;6:e011801 pdf
- Mastrodima S, Akolekar R, Yerlikaya G, Tzelepis T, Nicolaides KH. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks. Ultrasound Obstet Gynecol 2016;48:613-7 pdf
- Tayyar A, Krithinakis K, Wright A, Wright D, Nicolaides KH. Mean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol 2016;47:573-9 pdf
- Sonek JD, Kagan KO, Nicolaides KH. Inverted Pyramid of Care. Clin Lab Med 2016;36:305-17 pdf
- Oliveira N, Poon LC, Nicolaides KH, Baschat AA. First trimester prediction of HELLP syndrome. Prenat Diagn 2016;36:29-33 pdf
- Frick AP, Nicolaides KH, Poon LC. Contingent Screening for Small by Weight for Gestational Age Neonates. Pediatr Endocrinol Rev 2016;13:568-73
- Andrietti S, Silva M, Wright A, Wright D, Nicolaides KH. Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation. Ultrasound Obstet Gynecol 2016;48:72-9 pdf
- Tsiakkas A, Saiid Y, Wright A, Wright D, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation. Am J Obstet Gynecol 2016;215:87.e1-87.e17 pdf
- Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. Am J Obstet Gynecol 2016;214:619.e1-619.e17 pdf
- O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol 2016;214:103.e1-103.e12 pdf
- Valino N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol 2016;47:203-9 pdf